For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Gigagen, Inc.

USPTO Granted Patents = 21

EPO Patents = 4

Trademarks = 4

Forward Citations = 31

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

David Scott Johnson (21 out of 27 patents)

Adam Shultz Adler (15 out of 19 patents)

Rena Aviva Mizrahi (15 out of 17 patents)

4. Everett Hurteau Meyer (6 out of 13 patents)

5. Matthew James Spindler (5 out of 7 patents)

6. Yoong Wearn Lim (4 out of 6 patents)

7. Michael Asensio (4 out of 5 patents)

8. Kacy Stadtmiller (3 out of 3 patents)

9. Sheila Keating (3 out of 3 patents)

10. Angelica V Medina-Cucurella (3 out of 3 patents)

11. Ariel Niedecken (3 out of 3 patents)

12. Emily Benzie (3 out of 3 patents)

13. Erica Lyn Stone (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof (2025-09-23),

2. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2025-09-02),

3. 12241178 - Recombinant fusion proteins and libraries from immune cell repertoires (2025-03-04),

4. 12195880 - Systems and methods for massively parallel combinatorial analysis of single cells (2025-01-14),

5. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof (2023-08-08),

6. 11702765 - Recombinant fusion proteins and libraries from immune cell repertoires (2023-07-18),

7. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2023-06-27),

8. 11591652 - System and methods for massively parallel analysis of nucleic acids in single cells (2023-02-28),

9. 11441240 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-09-13),

10. 11427933 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-08-30),

11. 11111490 - Systems and methods for massively parallel combinatorial analysis of single cells (2021-09-07),

12. 11053543 - System and methods for massively parallel analysis of nucleic acids in single cells (2021-07-06),

13. 10787706 - System and methods for massively parallel analysis of nucleic acids in single cells (2020-09-29),

14. 10689641 - Recombinant fusion proteins and libraries from immune cell repertoires (2020-06-23),

15. 10465243 - System and methods for massively parallel analysis of nucleic acids in single cells (2019-11-05),

GigaGen, Inc. is a biotechnology company specializing in developing novel antibody therapies. Leveraging its proprietary technology platform, the company identifies and isolates human antibodies to create high-quality libraries for therapeutic use. GigaGen's innovative approach allows for the rapid discovery and development of targeted therapies for various diseases, including autoimmune disorders and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

21 Patents

#59 in South San Francisco, CA

#3,616 in California

#15,159 in US

#29,047 in the World

South San Francisco, CA, United States of America

Gigagen, Inc.

Forward Citations = 31

13 inventors:

David Scott Johnson (21 out of 27 patents)

Adam Shultz Adler (15 out of 19 patents)

Rena Aviva Mizrahi (15 out of 17 patents)

4. Everett Hurteau Meyer (6 out of 13 patents)

5. Matthew James Spindler (5 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…